Editor's Statement

The medical device industry continues to remain hardy. Revenue estimates for the global medical device industry range from $220 billion to $375 billion annually. Growth estimates for the global medical device industry and its sectors range from 6 to 10% CAGR. In terms of valuation ratios, profitability ratios, and other categories, the device industry outperformed the S&P 500 in 2007. Over the last five years, the medical device sector has averaged gross margins of 60%, which is 15% higher than the average gross margins of the S&P 500.

Over the last five years, the medical device sector has averaged gross margins of 60%, which is 15% higher than the average gross margins of the S&P 500. Also in 2007, the medtech industry’s top 25 companies reported year-over-year revenue increases of 9.7%, with 15 of the firms posting double-digit gains. Those companies generated $173.5 billion in sales, compared with $158.1 billion in 2006.

 

 

As you address this complex market, you can rest assured that MD&DI will help you develop, design, and manufacture medical products that comply with demanding regulations and market requirements. Articles, special sections, and industry interviews are among the many tools that MD&DI provides device manufacturers to help you design and develop your products. As critical areas emerge, we provide supplements to help readers like you address the issues surrounding new technologies and markets. 

 

 

 

MD&DI is unique in the industry. It is peer-reviewed by an elite editorial advisory board. The magazine’s feature articles offer authoritative perspectives and provide a valuable reference on the full range of device industry issues. In addition to peer-reviewed articles by leading experts on specific technology issues, broader features offer overviews of key business, industry, and regulatory topics.

 

 

 

The medical device industry continues to evolve as medical device technologies and products are become increasingly sophisticated. While this trend is contributing to the industry’s strong growth and improving the standard of care, it also presents engineering, design, and regulatory challenges the industry has not faced before. Devices are also increasingly converging with drug-related technologies. Converging areas such as genomics, proteomics, and nanotechnology have created new diagnostic and therapeutic possibilities. Moreover, these converging areas have presented a new avenue for product innovation and an opportunity for the development of more personalized medicine.

 

 

So, as you face these challenges, MD&DI will be there with you.

 

 

Sherrie Conroy